New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 24, 2012
10:25 EDTAGN, VPHM, TWX, RBCN, STR, PVH, LAMR, CTB, BODY, RHIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Outperform from Underperform at CLSA... Body Central (BODY) upgraded to Outperform from Perform at Oppenheimer... Cooper Tire (CTB) upgraded to Buy from Hold at Deutsche Bank... Lamar Advertising (LAMR) upgraded to Outperform from Market Perform at Wells Fargo... PVH Corp. (PVH) upgraded to Overweight from Neutral at Piper Jaffray... Questar (STR) upgraded to Buy from Neutral at UBS... Rubicon (RBCN) upgraded to Neutral from Sell at Goldman... Time Warner (TWX) upgraded to Overweight from Equal Weight at Morgan Stanley... ViroPharma (VPHM) upgraded to Outperform from Market Perform at Wells Fargo... Robert Half (RHI) upgraded to Buy from Neutral at BofA/Merrill.
News For AGN;BODY;CTB;LAMR;PVH;STR;RBCN;TWX;VPHM;RHI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 15, 2014
10:55 EDTTWXHBO to launch standalone online service in 2015
HBO's plans to launch a stand alone streaming service in the U.S. that does not require a cable TV subscription were announced at Time Warner's (TWX) analyst day meeting. HBO's upcoming service may be viewed as another competitor to Netflix (NFLX).
10:03 EDTTWXTime Warner's Turner unit sees low double-digit operating income CAGR 2013-18
Subscribe for More Information
09:59 EDTTWXTime Warner CEO says has more than sufficient scale, sees doubling EPS
Subscribe for More Information
09:52 EDTTWXTime Warner CEO sees investing more in content over time
Time Warner notes it invested $13.8B in content in 2013. Time Warner CEO Jeff Bewkes is speaking at the company's investor day meeting.
09:51 EDTTWXTime Warner sees adjusted EPS $6 by 2016, $8 by 2018
Subscribe for More Information
October 14, 2014
06:03 EDTAGNMarket overreacted to new Irish tax rules, says BMO Capital
BMO Capital believes the market may have overreacted yesterday to the report that Ireland is eliminating the "Double Irish" tax loophole. The firm says Allergan (AGN) confirmed that it incorporated potential changes to Irish tax law in its recently raised earnings guidance while Mallinckrodt (MNK) said it does expect the new tax structure to have an immediate impact. BMO views yesterday's pullback in shares of Allergan, Mallinckrodt and Actavis (ACT) as an overreaction.
October 13, 2014
10:08 EDTCTBOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:53 EDTRBCNRubicon shares undervalued, says Dougherty
Dougherty said Rubicon continues to sampling its rectangular shaped sapphire blocks with several smartphone OEM manufacturers and is well positioned if this market segment takes off. The firm views shares as undervalued and reiterates its Buy rating and $11 price target.
07:14 EDTCTBCooper Tire upgraded to Buy from Neutral at SunTrust
Subscribe for More Information
06:39 EDTAGNAllergan takeout value at or above $210 per share, says Leerink
Leerink believes Allergan's takeover value is now at or above $210 per share given the company's recent execution. After speaking with management, the firm says Allergan's upside in Q3 was driving by fundamentals, not cost cuts. It continues to view the "most likely and straightforward outcome" for Allergan as being an outright sale of the company. Leerink raised its price target for shares to $215 from $184 and keeps an Outperform rating on Allergan.
October 10, 2014
17:14 EDTAGNMarket ends week lower amid global growth worries
Subscribe for More Information
13:34 EDTRBCNRubicon Technology volatility increases on sharp rally
Rubicon Technology October call option implied volatility is at 148, November is at 181, December is at 206; compared to its 26-week average of 60 according to Track Data, suggesting large near term price movement.
13:23 EDTRBCNRubicon halted for volatility after jumping 34% to $5.39
Subscribe for More Information
10:20 EDTAGNFidelity supports potential merger between Actavis and Allergan, Reuters reports
Subscribe for More Information
07:37 EDTAGNActavis more likely partner than Valeant if Allergan merges, says UBS
Subscribe for More Information
07:35 EDTAGNAllergan price target raised to $224-$225, from $198-$199 at Wells Fargo
Wells Fargo increased its price target on Allergan after the company pre-released better-than-expected revenue and EPS, and raised its 2014-2016 EPS guidance. The firm keeps an Outperform rating on the shares.
07:16 EDTAGNAmerican Society of Plastic Surgeons to hold annual meeting
Annual Meeting of ASPS is being held in Chicago on October 10-14.
07:04 EDTTWXAmazon in talks to join digital locker for movies. WSJ reports
Subscribe for More Information
06:42 EDTTWXTime Warner CEO to be questioned on growth plans, NY Post reports
Subscribe for More Information
05:18 EDTTWXTime Warner to host investor meeting
Investor meeting to be held on October 15 at 9:30 am. Webcast Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use